Dehydroepiandrosterone and Effective Treatment for Major Depression

 

Major depression affects 20 million Americans a year. Many American are suffering from clinical depression without even knowing. Signs of depression are loss of energy, suicidal thoughts, increase sleep, decreased appetite, loss of libido and loss of interest in normal activities. Depression cases are on the increase as economic hard times have affected many Americans. There currently are several prescription products available to treat major depression on the market. These products have shown effectiveness but are often discontinued due to the long list of side effects associated with them. We will explore current therapies and also learn about alternatives such as Dehydroepiandrosterone which has been clinically proven to reduce symptoms of major depression. (AJP) 1999

 

Products such as Prozac, Zoloft, Lexapro, Paxil and Effexor have all been clinically proven to treat depression. These products belong to a class of antidepressants known as SSRIs. This class of antidepressants generates revenues of over 10 billion dollars annually. Although clinically proven to treat depression, these products are also layered with side effects. Common side effects are weight gain and inorgasmia. The challenge with these side effects is that although your depression has improved, you now have to deal with the negative effects of being overweight and sexually inadequate. It is common for patients to either discontinue using these products or have to add products such as Viagra to combat the nasty side effects. Sometimes the origin of depression is sexual dysfunction or being overweight. Although proven effective, it is clear that current treatment with SSRIs has clear limitations.

 

Based on the clear need for alternatives, researchers at Biopharm Nutraceuticals Corp began research on the effectiveness of Dehydroepiandrosterone for treating major depression.  In a clinical trial published in the reputable psychiatric journal (AJP) American Journal of Psychiatry, Dr. Michael Wolokowitz proved that Dehydroepiandrosterone was an effective treatment for treating major depression. Based on this landmark clinical trial, Biopharm Nutraceuticals began production of the blockbuster multisupplement Vimulti. Dehydroepiandrosterone has also been clinically proven to reduce belly fat and treat sexual dysfunction in men and women. Dehydroepiandrosterone may be the ideal treatment in treating depression due to the effectiveness as well as the improvements in weight and sexual function. Visit www.vimulti.com to read the clinical data surrounding Dehydroepiandrosterone. Although Dehydroepiandrosterone shows much promise, it is clear that more clinical research has to be done to uncover other uses for this natural occuring hormone.